MedPath

Arstasis, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

Access Safety and Efficacy Post Endovascular Intervention

Not Applicable
Conditions
Cardiovascular Disease.
First Posted Date
2013-01-23
Last Posted Date
2015-02-24
Lead Sponsor
Arstasis, Inc.
Target Recruit Count
240
Registration Number
NCT01773148
Locations
🇺🇸

Heart Center Research, LLC, Huntsville, Alabama, United States

🇺🇸

Arkansas Heart Hospital, Little Rock, Arkansas, United States

🇺🇸

Scripps Green, La Jolla, California, United States

and more 14 locations

A Patient Registry Evaluating Closure Following Access With the ArstasisOne Access System

Not Applicable
Completed
Conditions
Diagnostic Catheterization Access Through a 5F or 6F Femoral Artery Introducer
First Posted Date
2011-01-07
Last Posted Date
2013-01-31
Lead Sponsor
Arstasis, Inc.
Target Recruit Count
351
Registration Number
NCT01271946
Locations
🇺🇸

The Cardiovascular Center, Parker, Arizona, United States

🇺🇸

Sequoia Hospital, Redwood City, California, United States

🇺🇸

P&S Surgical Hospital, Monroe, Louisiana, United States

and more 5 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.